Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)
Clinical trial NCT03261739 · COMPLETED
Trial details
- NCT number
- NCT03261739
- Sponsor
- Bird Rock Bio, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-28
- Primary completion
- 2018-08-24
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.